Share on LinkedInShare on LinkedIn

ARTICLE · 07 DECEMBER 2018

India's Tryst With "Evergreening" – An Ongoing Battle.

S&A Law Offices
S&A Law Offices
Contributor
S&A Law Offices

S&A Law Offices

S&A Law Offices is a full-service law firm headquartered in Delhi NCR. The firm has 300+...

View firm profile
Explore more from S&A Law Offices

Evergreening is the term used for legal and technological alternatives adopted by Pharmaceutical companies to extend their exclusivity of over production and sale of patented medicines...

IndiaIntellectual Property

Evergreening is the term used for legal and technological alternatives adopted by Pharmaceutical companies to extend their exclusivity of over production and sale of patented medicines beyond the prescribed statutory timeline of 20 years. The said alternatives enable Pharma companies to retain royalties from patented medicines by either taking out new patents over minor incremental innovation, for example, associated delivery systems, or new pharmaceutical mixtures with a hidden motive of extended exclusivity over the main patented medicine beyond the prescribed time

The main purpose of research and development for a pharma company is to invent an entirely new medicine or a 'blockbuster' drug, which would disrupt the market in a therapeutic domain. This blockbuster drug is aggressively patented for varied compositions. Strictest of patent monopoly is enforced by the company to prevent and more than often killing the competition in such therapeutic domain. Hence, the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from